Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation

M Rahimifard, F Maqbool, S Moeini-Nodeh… - Ageing research …, 2017 - Elsevier
A wide array of cell signaling mediators and their interactions play vital roles in
neuroinflammation associated with ischemia, brain trauma, developmental disorders and …

Endothelial dysfunction in obesity

A Engin - Obesity and lipotoxicity, 2017 - Springer
Chronic inflammatory state in obesity causes dysregulation of the endocrine and paracrine
actions of adipocyte-derived factors, which disrupt vascular homeostasis and contribute to …

Characterization of the role of nitric oxide and its clinical applications

AB Levine, D Punihaole, TB Levine - Cardiology, 2012 - karger.com
Nitric oxide (NO) has long been known as endothelium-derived relaxing factor. It is a
vasodilator, modulating vascular tone, blood pressure and hemodynamics, a role exploited …

Enterosalivary nitrate metabolism and the microbiome: intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health

CD Koch, MT Gladwin, BA Freeman… - Free Radical Biology …, 2017 - Elsevier
Recent insights into the bioactivation and signaling actions of inorganic, dietary nitrate and
nitrite now suggest a critical role for the microbiome in the development of cardiac and …

Endothelial senescence contributes to heart failure with preserved ejection fraction in an aging mouse model

AB Gevaert, H Shakeri, AJ Leloup… - Circulation: Heart …, 2017 - Am Heart Assoc
Background—Because of global aging, the prevalence of heart failure with preserved
ejection fraction (HFpEF) continues to rise. Although HFpEF pathophysiology remains …

Soluble guanylate cyclase stimulators in pulmonary hypertension

JP Stasch, OV Evgenov - Pharmacotherapy of Pulmonary Hypertension, 2013 - Springer
Soluble guanylate cyclase (sGC) is a key enzyme in the nitric oxide (NO) signalling pathway.
On binding of NO to its prosthetic haem group, sGC catalyses the synthesis of the second …

Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease

N Tzoumas, TE Farrah, N Dhaun… - British Journal of …, 2020 - Wiley Online Library
PDE type 5 inhibitors (PDE5Is), such as sildenafil, tadalafil and vardenafil, are a class of
drugs used to prolong the physiological effects of NO/cGMP signalling in tissues through the …

[HTML][HTML] Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure

SS Soskić, BD Dobutović, EM Sudar… - The open …, 2011 - ncbi.nlm.nih.gov
Nitric oxide synthases (NOS) are the enzymes responsible for nitric oxide (NO) generation.
NO is a reactive oxygen species as well as a reactive nitrogen species. It is a free radical …

[HTML][HTML] Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome

N Schlueter, A de Sterke, DM Willmes… - Pharmacology & …, 2014 - Elsevier
Natriuretic peptides (NPs) are a group of peptide-hormones mainly secreted from the heart,
signaling via c-GMP coupled receptors. NP are well known for their renal and cardiovascular …

Obesity and risk of vascular disease: importance of endothelium‐dependent vasoconstriction

M Barton, O Baretella, MR Meyer - British journal of …, 2012 - Wiley Online Library
Obesity has become a serious global health issue affecting both adults and children. Recent
devolopments in world demographics and declining health status of the world's population …